EcoSynthetix Reports 2025 Third Quarter Results

Executive Summary

• EcoSynthetix reported Q3 2025 net sales of $5.8 M, up 11% YoY, driven by higher volumes and modest price gains.
• Adjusted EBITDA fell to $0.2 M from $0.4 M a year earlier, while the company posted a small quarterly loss of $0.1 M (‑$0.00 per share).
• The firm secured two new European commercial accounts for its SurfLock™ strength aid and received a $0.8 M purchase order from a global pulp manufacturer; cash and term deposits stood at $30.4 M as of September 30, 2025.

Key Details

• Net Sales: $5.8 M (Q3) vs. $5.2 M YoY; YTD sales $14.9 M vs. $13.1 M YoY.
• Volume Impact: +10% volume contribution ($0.5 M) and +1% price contribution ($0.1 M) to quarterly growth.
• Gross Profit: $1.7 M (Q3), flat YoY; YTD gross profit $4.0 M vs. $3.7 M prior year. Gross margin fell to 29.9% (Q3) from 33.3% YoY.
• Adjusted EBITDA: $0.2 M (Q3) vs. $0.4 M YoY; YTD adjusted EBITDA loss improved by $0.9 M versus prior year.
• Net Loss: Q3 loss of $0.1 M (‑$0.00 per share); YTD loss of $0.6 M (‑$0.01 per share) vs. a $1.2 M loss YoY.
• SG&A Expenses: $1.8 M (Q3), up from $1.5 M YoY, mainly higher salaries and maintenance costs.
• R&D Expenses: $0.4 M (Q3), down from $0.6 M YoY; YTD $1.2 M vs. $1.7 M prior year.
• Share Repurchases: 118,035 shares cancelled in Q3 for $0.4 M under the normal course issuer bid (NCIB). Total NCIB repurchases YTD: 345,635 shares for $1.0 M.
• Liquidity: Cash & term deposits $30.4 M at quarter‑end (down from $32.2 M Dec 31 2024).
• Commercial Wins: Two new European accounts for SurfLock™ in tissue market; $0.8 M purchase order from a leading global pulp manufacturer, with additional purchases expected before year‑end.
• Conference Call: Scheduled for Friday, 7 Nov 2025 at 08:00 ET; CEO Jeff MacDonald and CFO Robert Haire to present results.

Notable Quotes

“We are building positive momentum with new account wins… The recent wins in the tissue end market are indicative of the value our strength aids offer across multiple applications.” – Jeff MacDonald, CEO

All forward‑looking statements are subject to risks and uncertainties detailed in the full release.